CITI on Divis Labs
Buy, TP Rs 6850
In a latest ruling US Federal Circuit has reversed district court’s earlier ruling on Entresto &amp; affirmed that patent expiring in July 2025 is not invalid.
With this ruling, generic launch has been averted at least till July 2025 
@CNBCTV18News